Insulin aspart, recombinant Subcutaneous and Pancof XP
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pancof XP and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: guaifenesin / hydrocodone
Brand name: Xtrelus
Synonyms: Pancof XP (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pancreatin
- Insulin aspart, recombinant Subcutaneous-Pancreatin 4X
- Insulin aspart, recombinant Subcutaneous-Pancreatin Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Pancreaze
- Insulin aspart, recombinant Subcutaneous-Pancrelipase
- Insulin aspart, recombinant Subcutaneous-Pancrelipase Capsules
- Pancof XP-Insulin degludec
- Pancof XP-Insulin Degludec (U-100) Prefilled Pens
- Pancof XP-Insulin Degludec (U-100) Vials
- Pancof XP-Insulin Degludec (U-200) Prefilled Pens
- Pancof XP-Insulin degludec and liraglutide
- Pancof XP-Insulin degludec and liraglutide Subcutaneous